KU-55933 (ATM Kinase Inhibitor)

For research use only.

Catalog No.S1092

250 publications

KU-55933 (ATM Kinase Inhibitor) Chemical Structure

CAS No. 587871-26-9

KU-55933 (ATM Kinase Inhibitor) is a potent and specific ATM inhibitor with IC50/Ki of 12.9 nM/2.2 nM in cell-free assays, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR. KU‑55933 (ATM Kinase Inhibitor) inhibits the activation of autophagy‑initiating kinase ULK1 and results in a significant decrease of autophagy.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 112 In stock
USD 70 In stock
USD 120 In stock
USD 370 In stock
USD 947 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's KU-55933 (ATM Kinase Inhibitor) has been cited by 250 publications

Purity & Quality Control

Choose Selective ATM/ATR Inhibitors

Biological Activity

Description KU-55933 (ATM Kinase Inhibitor) is a potent and specific ATM inhibitor with IC50/Ki of 12.9 nM/2.2 nM in cell-free assays, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR. KU‑55933 (ATM Kinase Inhibitor) inhibits the activation of autophagy‑initiating kinase ULK1 and results in a significant decrease of autophagy.
Targets
ATM [1]
(Cell-free assay)
12.9 nM
In vitro

KU-55933 inhibits DNA-PK and PI3K with IC50 of 2.5 μM and 16.6 μM, respectively. Besides, KU-55933 also prevents the activity of mTOR with IC50 of 9.3 μM. KU-55933 is active at the cellular level in ablating a well-characterized ATM-dependent phosphorylation event. KU-55933 has a dose-dependent effect in inhibiting this ATM-dependent phosphorylation event with IC50 of 300 nM. KU-58050 does not prevent the ATM-dependent phosphorylation of p53 serine 15 until a dose of 30 μM. Addition of KU-55933 has no appreciable effects on UV-induced phosphorylation of H2AX on serine 139, NBS1 on serine 343, CHK1 on serine 345, and SMC1 on serine 966. In stark contrast to the UV responses, KU-55933 ablates the ionizing radiation-induced phosphorylation of these ATM substrates. KU-55933 sensitizes HeLa cells to a range of ionizing radiation doses. [1] KU-55933 inhibits the phosphorylation of Akt induced by growth factors in cancer cells. KU-55933 suppresses the proliferation of cancer cells. Furthermore, suppression of ATM by KU-55933 improves survival, probably via prevention of downstream activation of TAp63α. [2]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
DU-145 NF\1RVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3LTNGlEPTB;Mz6yO|M2OiEQvF2= NInVW3M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HuO-3N1 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3noUmlEPTB;ND6xO|E1OiEQvF2= MlTpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
LAMA-84 NXfqRoVwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkTJTWM2OD12LkW4OFY2KM7:TR?= NFjxe|I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
CAL-72 NEHGS|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NULCcYlLUUN3ME21MlQ5ODh2IN88US=> NFHueWw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
LoVo NV[yXFlwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVr0R2VnUUN3ME22Mlk{OjN7IN88US=> MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
HH MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV7EXIM5UUN3ME24MlI4PjdzIN88US=> MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
SK-MEL-3 NIC0S4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3HoTmlEPTB;OD6yPFU4PSEQvF2= NWrVfoRwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
KM12 MmDSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWfkdIJ3UUN3ME25MlIyOTR{IN88US=> Mk\lQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
NCI-H1437 NVLtOJlNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWXBV5JyUUN3ME25MlgxQTdizszN NEj5ZYM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
NCI-H1838 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlfETWM2OD1zMT6xPFY2KM7:TR?= NIPS[nE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
J-RT3-T3-5 NIn5bXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUfw[YZjUUN3ME2xNU4zPDF5IN88US=> MnroQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
GOTO NVfuZ3I1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2PGeWlEPTB;MUGuOlk6PiEQvF2= NHjENWw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
LB2241-RCC NGH3c49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkflTWM2OD1zMT63NVg3KM7:TR?= NF7oOnk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
ES7 NGHCPXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWnJR|UxRTFzLke4PEDPxE1? M{jXd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
KP-N-YS MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWDJR|UxRTF{Lk[zOVQh|ryP MmnzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
CAL-12T MkW2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{PiOmlEPTB;MUOuOlE4KM7:TR?= M{XsT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
COLO-684 Mn\mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlvtTWM2OD1zND6xOVY6KM7:TR?= MonUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
DOK NGXlNYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2L6fmlEPTB;MUWuN|MzQSEQvF2= M13tWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
Hs-578-T NILTS2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2XHbmlEPTB;MUWuOFE5OiEQvF2= M2nFclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
D-423MG NV7JZYwyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3vGNmlEPTB;MUWuOVI{PiEQvF2= M3OwWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
DBTRG-05MG MkT5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYnJR|UxRTF3Lk[xNVEh|ryP M4X1bFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
VM-CUB-1 MlzyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIOzOoVKSzVyPUG1Mlk5PDlizszN M1:2WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
KG-1 NXrFenRMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml;1TWM2OD1zNj6wPVk3KM7:TR?= NV3oNnRjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
8305C M3y5WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmTuTWM2OD1zNj6xPFg6KM7:TR?= M37ER|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HuH-7 MlPES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml\GTWM2OD1zNj6yOlc1KM7:TR?= M4qxUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
LXF-289 NULaNWw3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3TpW2lEPTB;MU[uNlc1PyEQvF2= Mk[5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
NCI-H1793 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3nvZ2lEPTB;MU[uOFcyOiEQvF2= NYH0UGJtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
ChaGo-K-1 NYjTNGdTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX\JR|UxRTF4Lk[1Olgh|ryP NGf2eGw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
GCIY M{HP[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVTJR|UxRTF4Lke5NFUh|ryP MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
SK-MEL-28 M2rBWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXfJR|UxRTF5LkC0O|Uh|ryP MnvpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
NCI-SNU-1 M4PBbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{PSO2lEPTB;MUeuNVI3QSEQvF2= NYHLUYdrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
CTB-1 M{jLeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2S0SWlEPTB;MUeuNlI2QSEQvF2= NX7DUokzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
NCI-H82 NGDUPFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mmr4TWM2OD1zNz60OVc{KM7:TR?= M1XTWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HCC2998 MlSyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoXqTWM2OD1zNz62O|M{KM7:TR?= MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
NCI-H2030 MlfVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHHuXY9KSzVyPUG4MlE6QTdizszN MlfVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
HuP-T3 MonLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXXRc|V7UUN3ME2xPE42QDh6IN88US=> M1rv[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
697 MlnoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUPJR|UxRTF7LkCyNFEh|ryP NHXkSmY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
MLMA NHfBSZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIe0[VRKSzVyPUG5MlA2PTdizszN MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
HCC70 M3f2Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NILub|VKSzVyPUG5MlQ5QSEQvF2= MkWxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
A704 NFLsUWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEn4N29KSzVyPUG5Mlg{ODVizszN NE\HU489[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
D-283MED NVLYcXRbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWfJR|UxRTJyLkWzN|kh|ryP NX\kU3BoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
U031 M373PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVjsZpRlUUN3ME2yNU4yPDh7IN88US=> NX61NpdvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
HSC-3 NIL6XXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXnJR|UxRTJzLkG4N|Uh|ryP MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
JVM-3 NY\LeINTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH3UW5RKSzVyPUKyMlUxPiEQvF2= NIrWc3I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
Mewo MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml\vTWM2OD1{Mj61NFc{KM7:TR?= M2P5dFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
YH-13 NVHhTWVOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXfJR|UxRTJ{LkWxNlMh|ryP M{\PXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
LB1047-RCC M4PaSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3XaR2lEPTB;MkKuOVg4QSEQvF2= NXHBT5lFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
HCC2157 M2LKVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkLuTWM2OD1{Mj64NFU1KM7:TR?= Mk\qQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
SNU-449 NGDQcG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUXJR|UxRTJ{Lki3OFgh|ryP NITVWok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
Ramos-2G6-4C10 NGqwOolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV;vWZhyUUN3ME2yNk46PiEQvF2= NGDWXmk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
CHL-1 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYfJR|UxRTJ|LkeyPVIh|ryP NEPrbmU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
SK-MEL-30 NFy4RXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUnJR|UxRTJ2LkS2OlIh|ryP NIPBcJI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
PANC-08-13 NF:ycI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoXUTWM2OD1{NT6wPVM5KM7:TR?= NXq2S45GRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
QIMR-WIL MnzCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkfYTWM2OD1{NT6xPFU5KM7:TR?= MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
BFTC-905 NHLRUHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV;JR|UxRTJ3LkW5OFQh|ryP M3j2RlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
GI-1 NGCwVJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWDCO4RoUUN3ME2yOU44ODV3IN88US=> M1jOVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
MDA-MB-415 NGfjelJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUnmS|VRUUN3ME2yOk42ODN|IN88US=> MmHXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
GT3TKB MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYLJR|UxRTJ4LkWzOFIh|ryP M1L0O|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
DEL M{O5R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFL4Om9KSzVyPUK2Mlg{PTZizszN NFfjW209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
KOSC-2 NGThcGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3ThUWlEPTB;Mk[uPVA4PSEQvF2= MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
RVH-421 M1\FOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUnJR|UxRTJ5LkK5NlEh|ryP Mmj2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
EW-13 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlfHTWM2OD1{Nz60N|A5KM7:TR?= MlrqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
639-V MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2jBPGlEPTB;MkeuOVEyQSEQvF2= MkLZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
A2780 NGjJfY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{TFN2lEPTB;MkeuOlQyKM7:TR?= MoHYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
SW982 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NY[4OoQ{UUN3ME2yO{46ODV{IN88US=> MmnjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
SW1710 M3L2cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHqxNHFKSzVyPUK4MlA6QDFizszN NEfPVY09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HCC1569 NF;Oe49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX3MSVlFUUN3ME2yPE41QDl5IN88US=> Mn\PQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
MV-4-11 NGHQV3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NETpPJJKSzVyPUK4MlU4OzVizszN Moe1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
BHT-101 M1PLfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWG0clNEUUN3ME2yPE43PTd{IN88US=> M1rrSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
Ca9-22 MmLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkfVTWM2OD1{OD63NVQh|ryP NVLvXI1wRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
HAL-01 NEfvW3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFy2bZRKSzVyPUK4Mlc3OTVizszN MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
D-263MG MonQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFu2cIlKSzVyPUK5MlM1PCEQvF2= M{nwWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
NEC8 M1rIVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2jFNWlEPTB;MkmuOVU1QCEQvF2= NXLlVmhwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
EKVX MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mlu2TWM2OD1|MT61PFQ4KM7:TR?= MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
EM-2 M4TueGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFnOe4dKSzVyPUOxMlY{ODRizszN M1L5ZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
MFM-223 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVH6eWpiUUN3ME2zNU45ODl6IN88US=> MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
SK-PN-DW NGjPcmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXvrcph3UUN3ME2zNk4yPDB4IN88US=> NVWx[Y4zRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
HuO9 Ml\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWW1bZI3UUN3ME2zNk42Ojh{IN88US=> NV\vT245RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
MHH-PREB-1 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\3XppKSzVyPUOyMlYzOzRizszN NH3ISYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
OVCAR-4 M{XzNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGTTV5RKSzVyPUOyMlg{PjNizszN MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
NCI-H1648 M4Xpdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{jCemlEPTB;M{KuPFY2OSEQvF2= Mn\SQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
MKN1 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NW\oT2RzUUN3ME2zOE4yOTBzIN88US=> NHTGN3E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
KYSE-450 M{nTXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnTXTWM2OD1|ND62OFQ1KM7:TR?= MoPlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
ES8 NULUfGV{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mnj6TWM2OD1|ND64PVc2KM7:TR?= NHPidpQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
MS-1 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV;JR|UxRTN2Lkm1OVQh|ryP NFfnb2g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HOP-92 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVTJR|UxRTN3LkmyO|ch|ryP M3rlSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
SKG-IIIa MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MW\JR|UxRTN4LkK1OlEh|ryP MnLSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
TE-11 NF7xbWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4rzcGlEPTB;M{[uOVI1OyEQvF2= NFzmW2s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
SK-NEP-1 M1THV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFnPVIJKSzVyPUO3MlY4PDRizszN NYrKN5lTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
DB MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX\WZlNuUUN3ME2zO{46OTh3IN88US=> NXLuOJNrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
IA-LM NEHhN3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mk\yTWM2OD1|OD6wNlM6KM7:TR?= MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
COLO-829 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV;vb4l4UUN3ME2zPE41OTV7IN88US=> Mk\rQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
TGBC11TKB MoPXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3r2cmlEPTB;M{muNVQxQCEQvF2= NFrQS3U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
CAL-51 NX7mNHhPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHSxXnlKSzVyPUSwMlA3OTJizszN NEXNS2E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
NCI-H2228 NYfXd3RpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mm\lTWM2OD12MD6zOlYzKM7:TR?= MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
C32 NHzDSIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX\JR|UxRTRyLkSwNlQh|ryP NHfVR2k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
KU-19-19 M3ntU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4LG[WlEPTB;NECuO|Y5OyEQvF2= Mkm3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
KNS-62 M1nqXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2mzd2lEPTB;NECuPFM5OSEQvF2= NIDUXVA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
FADU MmHKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV\obnh7UUN3ME20NU4zPTB{IN88US=> NW\p[o86RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
CAL-33 M{nrU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml7YTWM2OD12Mj62O|Q6KM7:TR?= MmjhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
CHP-134 M1qydmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4DqeGlEPTB;NEKuPFQ6PiEQvF2= M2\yTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HDLM-2 M4TwNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVXJR|UxRTR{LkmwPFQh|ryP NGjVU289[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
NBsusSR MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUDJR|UxRTR|LkC3NlUh|ryP NYPYSpJ2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
SW954 NWTTW5lYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV7BNpFKUUN3ME20N{4yODV|IN88US=> MkXiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
HCC1806 MlfES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{LXU2lEPTB;NEOuOFEyKM7:TR?= MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
VMRC-RCZ MoOzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlexTWM2OD12Mz60OVg3KM7:TR?= NHO2U|A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
A549 M2ruTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEfsSlNKSzVyPUSzMlk{OSEQvF2= MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
NKM-1 NXjCRZE3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXXJR|UxRTR|Lkm1OVgh|ryP MkDCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
DMS-273 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MU\JR|UxRTR2Lke1Olch|ryP M{jwOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
TYK-nu NXGzWW9jT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn\3TWM2OD12NT6xNlM1KM7:TR?= NX\tTlFuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
KALS-1 NYXzTYc2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVjXcXhbUUN3ME20OU4yPDZizszN NFXLSXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
A101D NYLUfZdKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUjnZno2UUN3ME20OU41PDV4IN88US=> MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
G-361 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYXwXHlbUUN3ME20Ok4zOTN6IN88US=> NVHa[G1rRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
KARPAS-299 NVPGSGIyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXP5T4t{UUN3ME20Ok4{PTF4IN88US=> NX\LNo5DRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
RS4-11 Ml7hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1\zUmlEPTB;NE[uOVQzKM7:TR?= NFzvPVE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HT-1376 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mnf3TWM2OD12Nj63OFI3KM7:TR?= NFK5dlI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
SK-N-AS MlLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml3RTWM2OD12Nj63PFIzKM7:TR?= MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
MG-63 NUDPVmx{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4LIcWlEPTB;NE[uPVA{PiEQvF2= M3vwW|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
EPLC-272H MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWm2bIJRUUN3ME20Ok46PTB|IN88US=> NWDST4xjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
BALL-1 M{TXNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTR5LkizNkDPxE1? NYTzeo9kRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
LCLC-97TM1 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1XNVGlEPTB;NEiuNlAzKM7:TR?= Mo\5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
HO-1-N-1 M2rxfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4n2NWlEPTB;NEiuPVY4PiEQvF2= NFi4d5I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
MFE-280 NV;LTWYzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3W0d2lEPTB;NEmuOFYyPyEQvF2= MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
NCI-H526 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGLK[4pKSzVyPUS5MlgyPjNizszN Moq0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
D-566MG MoXXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmnkTWM2OD12OT65NFk3KM7:TR?= MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
BB30-HNC M{jUXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3XGS2lEPTB;NEmuPVQ6QCEQvF2= MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
SK-N-DZ NXzLcpFUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmK5TWM2OD13MD6wOFgyKM7:TR?= NFPyfVk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HepG2  MmHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYfQ[lQ6OTEEoN88US=> NVzSdIpHOjRiaB?= M3fFZYJtd2OtczDTR{1KUUl|LXnu[JVk\WRiUzDwbIF{\SCjcoLld5Q> MlPRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV3MkexNlMoRjJ3NUK3NVI{RC:jPh?=
HepG2  M4\SemZ2dmO2aX;uJGF{e2G7 MUCxNOKh|ryP Ml3MNlQhcA>? M4jmdJN2eHC{ZYPz[ZMhfGinIIDoc5NxcG:{eXzheIlwdnNib3[gRXROKG:wIGPldlE6QDFuIFPob|Ehd25iU3XyN|Q2NCCFaHuyJI9vKFSqck[4MEBidmRiQ3TrNkBwdiCWeYKxOUBqdmS3Y3XkJIJ6KFOFLVnJTVM> MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTV{N{GyN{c,OjV3MkexNlM9N2F-
KATO III  M{HkOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXyyMlUwPS95LkWg{txO Mlr2SG1UVw>? MkHp[Y5p[W6lZYOgeIhmKHSxeHnjbZR6KG:oIH;sZZBiemmk MnLLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6NEG3NVgoRjJ2OESxO|E5RC:jPh?=
hTCEpi MnXDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkXiNVAh|ryP M1HJS2ROW09? MVTwdoV3\W62czD0bIUh[3m2b4DheIhq[yCnZn\lZ5Qhd2ZiSGPWMVE> NGL3XVQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEO3NFg{PSd-MkSzO|A5OzV:L3G+
MCF10A M4DmN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFLS[JIyOCEQvF2= M4PZSFI1KGh? M4G5WmROW09? MmXUdI91\W62aXH0[ZMhfGinIHP5eI91d3irY3n0fUBw\iCJQR?= M1nq[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2MUWwOVk2Lz5{NEG1NFU6PTxxYU6=
HL-60  NUnYXIhjTnWwY4Tpc44hSXO|YYm= M4jmTlExKM7:TR?= MlSxNE42KGh? M{HUcWROW09? M1rQbpJm\HWlZYOgdIhwe3Cqb4L5cIF1cW:wIH;mJGNpczMEoB?= NHL1bFY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mzOFQyOSd-MkO5N|Q1OTF:L3G+
MCF-7 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWKxMVExOM7:TR?= NWjtNHhnOjRiaB?= MX3GRnM> MnvSbY5pcWKrdIOgeIhmKGOnbHygdJJwdGmoZYLheIlwdg>? MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF6NUO0O{c,OjNzOEWzOFc9N2F-
HeLa  MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3PDbFEuOTByzszN NHm0cYEzPCCq NFTHcJlHSlN? NUP5W5ducW6qaXLpeJMhfGinIHPlcIwheHKxbHnm[ZJifGmxbh?= M{K2S|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MUi1N|Q4Lz5{M{G4OVM1PzxxYU6=
SH-SY5Y MYrGeY5kfGmxbjDBd5NigQ>? M2L3bFExyqEQvF5CpC=> M37WfFI1KGh? M17TVYlvcGmkaYTzJINtcW:zdXnuc4wucW6mdXPl[EBxcG:|cHjvdplt[XSrb36gc4YheDV| MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjZ{N{K5OEc,OjJ4MkeyPVQ9N2F-
IMR-32 MXPGeY5kfGmxbjDBd5NigQ>? MW[xNOKh|ryPwrC= NYDxNHczOjRiaB?= MXXpcohq[mm2czDjcIlweXWrbn;sMYlv\HWlZXSgdIhwe3Cqb4L5cIF1cW:wIH;mJJA2Ow>? NEnQNVc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mk[yO|I6PCd-MkK2NlczQTR:L3G+
A549 MW\GeY5kfGmxbjDBd5NigQ>? MVOxNOKh|ryPwrC= NUPSVWw2OSCq NX\vNmh3e3WycILld5NmeyCQYX7vMWNwNWmwZIXj[YQheDV|IHHjZ5VufWyjdHnvci=> M1yzdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NUW5N|IyLz5{MkW1PVMzOTxxYU6=
T47D  MkfRSpVv[3Srb36gRZN{[Xl? M1zHXFIxyqCvTR?= NWfoWHBrOjRiaB?= MlXGSG1UVw>? NIjQRVhxemW4ZX70d{BKWi2rbnT1Z4VlKGSnZ4Lh[IF1cW:wIH;mJGnPwkMQsR?= NUfNbYZVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxOFQ5ODVpPkKxNVQ1QDB3PD;hQi=>
A29 MEF MWXGeY5kfGmxbjDBd5NigQ>? MXSxNOKh|ryPwrC= MkTyNYg> MVHicI9kc3QEoITo[UBxcG:|cHjvdplt[XSrb36gc4YhSWu2IHH0JHNmejR5M9Mg M2rtRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMEWzO|gyLz5{MEC1N|c5OTxxYU6=
MDA-MB-453  M4\rPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWDtR3B{PS12MDFOwG0> M3X3SFczKGh? MlPoTWM2OCCxZjCxNEDPxE1? MmD6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjByNUO3PFEoRjJyMEWzO|gyRC:jPh?=
PC-3 NFzHS4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHXRRVM2NTRyIN88US=> M1jEcFczKGh? NX;qWJFiUUN3MDDv[kAyOCEQvF2= NXzIbpNFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCwOVM4QDFpPkKwNFU{PzhzPD;hQi=>
U2OS MUXGeY5kfGmxbjDhd5NigQ>? MljTTY5pcWKrdHnvckBw\iCDVF2gbY4hcHWvYX6gWVJQWyClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJJA2OyCyaH;zdIhwenmuYYTpc44h[XRiU3XyNVUhemW|aXT1[UwhUUN3MDC9JFAvOjVizszNMi=> M{fqUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NkOyPVY2Lz5{Nk[zNlk3PTxxYU6=
MCF7 Mni2SpVv[3Srb36gZZN{[Xl? MXuxJIhz M4PQ[2lvcGmkaYTpc44hd2ZiQWTNJItqdmG|ZTDpckBpfW2jbjDNR2Y4KGOnbHzzJIFnfGW{IEGgbJIh[nliaX3teY5w\my3b4Lld4NmdmOnIHHzd4F6NCCLQ{WwJF0hOC5|IN88UU4> NGm1eW89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Nk[zNlk3PSd-Mk[2N|I6PjV:L3G+
BJ MUPGeY5kfGmxbjDhd5NigQ>? MmD1NVAhfU1? M1ruPFExKGSjeYO= M2\oZ3N2eHC{ZYPzbY9vKG:oIIPlcoV{[2WwY3WgbY4hcHWvYX6gRmoh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iY3XscEBvfW2kZYKgZZQhOTBidV2gZYZ1\XJiMUCg[IF6eyCkeTDz[Y5me2OnbnPlJJJmfmW{c3HsJIF{e2G7 MlLoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTZ5NkewPFUoRjF4N{[3NFg2RC:jPh?=
BJ NV;ON3hXTnWwY4Tpc44h[XO|YYm= MYCxNEB2VQ>? M4Toe|ExKGSjeYO= MYDJcohq[mm2aX;uJI9nKGG2YYjpZUB1\Wyjbnfp[YN1[XOrYT3teZRifGWmIHnuJIh2dWGwIFLKJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGOnbHygcpVu[mW{IHH0JFExKHWPIHHmeIVzKDFyIHThfZMh[nlic3Xu[ZNk\W6lZTDy[ZZmenOjbDDhd5NigQ>? NX7jSYdtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMU[3OlcxQDVpPkG2O|Y4ODh3PD;hQi=>
MCF7 NF;V[GFHfW6ldHnvckBie3OjeR?= MmHYNVAhfU1? Mm\kNVAhdWmwcx?= MV3T[Y5{cXSrenH0bY9vKG:oIHnu[pJiemWmLXnu[JVk\WRiRF7BJIRidWGpZTDpckBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDjc4xwdnliZn;ycYF1cW:wIHH0JFExKHWPIIDy[ZRz\WG2ZXSg[o9zKDFyIH3pcpMh\m:ubH;3[YQh[nliaYLyZYRq[XSrb36g[o9zKDRiaILzJI1m[XO3cnXkJIFnfGW{IEGwJIRigXNiYomgZ5J6e3SjbDD2bY9t\XRic4ThbY5qdmdiYX7hcJl{cXN? NYX6W2FCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[2N|I6PjVpPkK2OlMzQTZ3PD;hQi=>
SK-N-MC M2fmUpFJXFNiYYPzZZk> NWnIdm1LeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> NUK5T4M6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-AKT(Ser473) / p-AKT(Thr308); 

PubMed: 22739265     


Cells were serum-starved for 6 h and treated with KU-55933 (10 µmol/L) for 1 h before treatment with insulin (100 nmol/L) for 45 min. Cells were lysed, and cell lysates were subjected to SDS-PAGE and Western blotting for the detection of phospho-Akt at Se䲧疝Ỵ疞㧀疜膉痘 瘿�෋ᾰƌ෋à 㺣痖

PARP / Cleaved PARP / Caspase-3 / Cleaved caspase-3 ; 

PubMed: 22739265     


ATM inhibition by KU-55933 induces apoptosis in differentiated but not undifferentiated SH-SY5Y cells. Cells were starved for 6 h in serum-free medium. KU-55933 (10 µmol/L) was added 1 h before insulin (100 nmol/L) treatment. After 3 h of insulin stimulat䲧疝Ỵ疞㧀疜膉痘 瘿�෋ᾰƌ෋à 㺣痖帉痖Ѐ瑖堘𢡄빢᎒෋à鑸᎒彿堙奋堙巫堙᎒ﻺ᎒彿堙ﻮ᎒塚堙ﻺ᎒ꍈ堞빢᎒學堙漸堞圔堙빢᎒圞堙圭堙𢡄玚Wᾰƌ ᾰƌ戤

ATM-S1981 / ATM / p-p53(S15) / p53 ; 

PubMed: 20639198     


Antioxidant and ATM inhibitors blocked phosphorylation of ATM-S1981, Akt-S473, and p53-S15 as stimulated by H2O2 exposure. Cells were treated with 100 μm H2O2 for 30 min in the absence or presence of KU-55933. Whole cell lysates were subjected to Western 䲧疝Ỵ疞㧀疜膉痘 瘿뾠ՂᾰƌՂĀ 㺣痖

p21 / p27 / p53 ; 

PubMed: 20177072     


HMGE cells were incubated for the indicated times with 1 μm KU-55933 or DMSO. Total protein extracts were analyzed by Western blotting for p21WAF1/CIP1, p27KIP1, p53, or β-actin.

22739265 20639198 20177072
Immunofluorescence
p-S824 KAP1 / ZEBRA ; 

PubMed: 28249048     


HH514-16 cells were treated with NaB (upper panel) or NaB plus KU-55933 (1μM; middle panel) or NaB plus Torin1 (0.5μM; lower panel) for 24 hours and stained with anti-phospho KAP1 (S824) plus anti-ZEBRA antibodies and visualized at 1000X magnification.

28249048
In vivo Suppression of ATM-dependent STAT3 activation by KU-55933 enhances TRAIL-mediated apoptosis through up-regulation of surface DR5 expression, whereas suppression of both STAT3 and NF-κB appeares to be involved in down-regulation of cFLIP accompanied by an additional increase in apoptotic levels. The ATM inhibitor KU-55933 affectes TRAIL-mediated apoptosis more strongly than the JAK2 inhibitor, AG490, or overexpression of STAT3β. [3]

Protocol

Kinase Assay:

[1]

- Collapse

Purified enzyme assays:

ATM for use in the in vitro assay is obtained from HeLa nuclear extract by immunoprecipitation with rabbit polyclonal antiserum raised to the COOH-terminal 400 amino acids of ATM in buffer containing 25 mM HEPES (pH 7.4), 2 mM MgCl2, 250 mM KCl, 500 μM EDTA, 100 μM Na3VO4, 10% v/v glycerol, and 0.1% v/v Igepal. ATM-antibody complexes are isolated from nuclear extract by incubating with protein A-Sepharose beads for 1 hour and then through centrifugation to recover the beads. In the well of a 96-well plate, ATM-containing Sepharose beads are incubated with 1 μg of substrate glutathione S-transferase–p53N66 (NH2-terminal 66 amino acids of p53 fused to glutathione S-transferase) in ATM assay buffer [25 mM HEPES (pH 7.4), 75 mM NaCl, 3 mM MgCl2, 2 mM MnCl2, 50 μM Na3VO4, 500 μM DTT, and 5% v/v glycerol] at 37 °C in the presence or absence of inhibitor. After 10 minutes with gentle shaking, ATP is added to a final concentration of 50 μM and the reaction continued at 37 °C for an additional 1 hour. The plate is centrifuged at 250 × g for 10 minutes (4 °C) to remove the ATM-containing beads, and the supernatant is removed and transferred to a white opaque 96-well plate and incubated at room temperature for 1.5 hours to allow glutathione S-transferase-p53N66 binding. This plate is then washed with PBS, blotted dry, and analyzed by a standard ELISA technique with a phospho-serine 15 p53 antibody. The detection of phosphorylated glutathione S-transferase-p53N66 substrate is performed in combination with a goat antimouse horseradish peroxidase-conjugated secondary antibody. Enhanced chemiluminescence solution is used to produce a signal and chemiluminescent detection is carried out.
Cell Research:

[1]

- Collapse
  • Cell lines: U2OS cells
  • Concentrations: 10 μM
  • Incubation Time: 2 hours
  • Method:

    U2OS cells are exposed to ionizing radiation (3, 5, or 15 Gy) or UV (5 or 50 J/m2) and the ATM response determined by Western blot analysis of p53 serine 15 phosphorylation and stabilization of wild-type p53. Whole cell extracts are obtained from each time point, proteins separated by SDS-PAGE, and the ATM-specific increase in phosphorylated serine 15 measured with a p53 phospho-serine 15 specific antibody. Overall p53 stabilization with time is also observed with a p53-specific antibody (DO-1). Similarly, for studying ATM-dependent phosphorylations on H2AX, CHK1, NBS1, and SMC1, the following antibodies are used: CHK1 phospho-serine 345 and NBS1 phospho-serine 343 antibodies. Histone H2A (H-124) and CHK1 antibodies are also used, as well as SMC1 and SMC1 phospho-serine 966 antibodies. For determination of a cellular IC50 for KU-55933, the peak response time for p53 serine 15 phosphorylation of 2 hours is used to monitor inhibition of ATM. KU-55933 is titrated onto cells and preincubated for 1 hour before ionizing radiation. Using scanning densitometry, the percentage inhibition relative to vehicle control is calculated, and the IC50 value is calculated as for the in vitro determinations.


    (Only for Reference)
Animal Research:

[3]

- Collapse
  • Animal Models: BALB/c nu/nu nude mice bearing LU1205 cells
  • Dosages: 10 μM
  • Administration: --
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 33 mg/mL (83.44 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5%DMSO+40%PEG300+5%Tween80+50%ddH2O
For best results, use promptly after mixing.
3.95 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 395.49
Formula

C21H17NO3S2

CAS No. 587871-26-9
Storage powder
in solvent
Synonyms N/A
Smiles C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

ATM/ATR Signaling Pathway Map

ATM/ATR Inhibitors with Unique Features

Related ATM/ATR Products

Tags: buy KU-55933 (ATM Kinase Inhibitor) | KU-55933 (ATM Kinase Inhibitor) supplier | purchase KU-55933 (ATM Kinase Inhibitor) | KU-55933 (ATM Kinase Inhibitor) cost | KU-55933 (ATM Kinase Inhibitor) manufacturer | order KU-55933 (ATM Kinase Inhibitor) | KU-55933 (ATM Kinase Inhibitor) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID